Evidence map›Paper›PMID 25691468›Full record

ArticleGenes & development2015

The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development, thymocyte expansion, and lymphomagenesis.

Masaki Miyazaki, Kazuko Miyazaki, Shuwen Chen, Vivek Chandra, Keisuke Wagatsuma, Yasutoshi Agata, Hans-Reimer Rodewald, Rintaro Saito, Aaron N Chang, Nissi Varki and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 38 citations in OpenAlex.

  1. HEB Restrains Effector Gene Expression during Early CD8Molecular and cellular biology · 2025
    Article
  2. Review
  3. Review
  4. MonoallelicFrontiers in immunology · 2022
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Cancer metabolism: New insights into classic characteristics.The Japanese dental science review · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Masaki MiyazakiDepartment of Molecular Biology, University of California at San Diego, La Jolla, California 92093, USA;
Kazuko MiyazakiDepartment of Molecular Biology, University of California at San Diego, La Jolla, California 92093, USA;
Shuwen ChenDepartment of Molecular Biology, University of California at San Diego, La Jolla, California 92093, USA;
Vivek ChandraDepartment of Molecular Biology, University of California at San Diego, La Jolla, California 92093, USA;
Keisuke WagatsumaDepartment of Biochemistry and Molecular Biology, Shiga University of Medical School, Shiga 520-2192, Japan;
Yasutoshi AgataDepartment of Biochemistry and Molecular Biology, Shiga University of Medical School, Shiga 520-2192, Japan;
Hans-Reimer RodewaldDivision of Cellular Immunology, German Cancer Research Center, D-69120 Heidelberg, Germany;
Rintaro SaitoDepartment of Medicine, University of California at San Diego, La Jolla, California 92093, USA;
Aaron N ChangCenter for Computational Biology, Institute for Genomic Medicine, University of California at San Diego, La Jolla, California 92093, USA;
Nissi VarkiDepartment of Pathology, University of California at San Diego, La Jolla, California 92093, USA;
Hiroshi KawamotoDepartment of Immunology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.
Cornelis MurreDepartment of Molecular Biology, University of California at San Diego, La Jolla, California 92093, USA; murre@biomail.ucsd.edu.
University of California, San Diego · USShiga University of Medical Science · JPHeidelberg University · DEKyoto University · JP

Funding

The role of TCR, ligand, and signal strength in human γδ T cell developmentP01AI102853 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI CORNELIS MURRE · 2014 to 2026
$26.3M
SYNTHETIC SYSTEMSP50GM085764 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HASTY, JEFF M, IDEKER, TREY · 2010 to 2018
$23.3M
TR&D 3 - Network Guided Machine LearningP41GM103504 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2012 to 2024
$17.3M
E2A as a Tumor SuppressorR01CA078384 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MURRE, CORNELIS · 1999 to 2013
$5.4M
E-proteins and EBF1 in B cell differentiationR01AI109599 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MURRE, CORNELIS · 2014 to 2017
$1.6M
European Research Council 233074NCI NIH HHS R01 CA078384NCI NIH HHS R01CA078384NIAID NIH HHS 1P01AI102853NIAID NIH HHS P01 AI102853NIAID NIH HHS R01 AI109599NIGMS NIH HHS P41 GM103504NIGMS NIH HHS P50 GM085764
6 · The paper itself

Abstract

It is now well established that the E and Id protein axis regulates multiple steps in lymphocyte development. However, it remains unknown how E and Id proteins mechanistically enforce and maintain the naïve T-cell fate. Here we show that Id2 and Id3 suppressed the development and expansion of innate variant follicular helper T (TFH) cells. Innate variant TFH cells required major histocompatibility complex (MHC) class I-like signaling and were associated with germinal center B cells. We found that Id2 and Id3 induced Foxo1 and Foxp1 expression to antagonize the activation of a TFH transcription signature. We show that Id2 and Id3 acted upstream of the Hif1a/Foxo/AKT/mTORC1 pathway as well as the c-myc/p19Arf module to control cellular expansion. We found that mice depleted for Id2 and Id3 expression developed colitis and αβ T-cell lymphomas. Lymphomas depleted for Id2 and Id3 expression displayed elevated levels of c-myc, whereas p19Arf abundance declined. Transcription signatures of Id2- and Id3-depleted lymphomas revealed similarities to genetic deficiencies associated with Burkitt lymphoma. We propose that, in response to antigen receptor and/or cytokine signaling, the E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to control cellular expansion and homeostatic proliferation.

Indexed as

Cell DifferentiationAnimalsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCell ProliferationCyclin-Dependent Kinase Inhibitor p16Gene Expression ProfilingGene Expression Regulation, NeoplasticHypoxia-Inducible Factor 1, alpha SubunitInhibitor of Differentiation ProteinsLymphoid TissueLymphomaMechanistic Target of Rapamycin Complex 1MiceMultiprotein ComplexesOncogene Protein v-aktPhosphatidylinositol 3-KinasesBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCdkn2a protein, mouseCyclin-Dependent Kinase Inhibitor p16Hypoxia-Inducible Factor 1, alpha SubunitInhibitor of Differentiation ProteinsMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesMyc protein, mouseOncogene Protein v-aktPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-mycSTAT1 Transcription FactorTOR Serine-Threonine Kinasesc-Myc/p19ArfFOXO/mTORC1 pathwayId proteinsT-cell lymphoma,T-cell quiescencetumor suppressor

Identifiers

PMID25691468
PMCPMC4335296
OpenAlexW2148878836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.